Investing in people
Lux Capital invests in emerging science and technology ventures at the outermost edges of what is possible.
We partner with iconoclastic inventors challenging the status quo and the laws of nature to bring their futuristic ideas to life.
Play Video Discover LUX"Securities" by Lux Capital
Ideas on science, technology, finance and the human condition
Subscribe to our weekly newsletter-
January 16, 2022
American Civil War 2.0
-
January 15, 2022
“Securities” by Lux Capital (Week of Jan 10, 2021)
-
January 11, 2022
Crypto, VR, and the dangers of accelerated tech adoption curves
-
January 10, 2022
The inevitable re-opening of late-stage startup finance
-
January 10, 2022
We need to create and foster new types of scientific organizations
-
January 7, 2022
“Securities” for the 21st Century
Our Companies
Want to know what the future will look like? Spend some time with our companies. You might meet a genetic engineer programming matter at the molecular level; a biologist and electrical engineer designing a new surgical robot; an astrophysicist launching rockets into space; or a materials scientist making circuits using a technique lifted from once-classified government programs.
-
AevaAeva has created a new sensing paradigm for autonomous machines. The company listed publicly [NYSE: AEVA] in 2021.
-
Auris Health
Auris Health is an ambitious robotics company based in Silicon Valley. Auris was acquired for up to $6.1B by Johnson & Johnson in 2019.
-
CTRL-labs
CTRL-labs is changing the way we interact with computers. CTRL-labs was acquired by Facebook in 2019.
-
Desktop Metal
Desktop Metal enables high-speed, high-performance, 3D metal printing at production scale. The company listed publicly [NYSE: DM] in 2020.
-
Latch
Latch is building the first universal smart-access platform. The company’s mission is to enable flexible, seamless and secure digital access to physical spaces. The company listed publicly [NASDAQ: LTCH] in 2021.
-
Matterport
Matterport is the world’s most powerful all-in-one 3D data platform lets you turn a space into an accurate and immersive digital twin. The company listed publicly [NASDAQ: MTTR] in 2021.
-
Recursion Pharmaceuticals
Recursion Pharma is combining high-throughput experimental biology, bioinformatics, and machine learning to rapidly identify new indications for many known drugs and shelved assets. The company completed its IPO [NASDAQ: RXRX] in 2021.
-
Saildrone
Saildrone collects valuable ocean data using a fleet of unmanned, autonomous sailing drones.
Our team is willing to take a chance on something other investors do not see.
We are neuroscientists, chemists, data scientists, computational biologists, economists, electrical engineers, machine-learning hackers and philosophers. We get fired up when audacious experimentation leads to heresy and reinvention.
